0001127602-11-019972.txt : 20110628 0001127602-11-019972.hdr.sgml : 20110628 20110628172003 ACCESSION NUMBER: 0001127602-11-019972 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110627 FILED AS OF DATE: 20110628 DATE AS OF CHANGE: 20110628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE KENNETH B JR CENTRAL INDEX KEY: 0001208570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 11936567 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-06-27 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001208570 LEE KENNETH B JR 4505 EMPEROR BLVD., SUITE 200 DURHAM NC 27703 1 Non-Qualified Stock Option 3.80 2011-06-27 4 A 0 22917 0 A 2011-06-30 2021-06-27 Common Stock 22917 22917 D Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan"). The option vests 1/12 per month for a period of 12 months, beginning on June 30, 2011. /s/ Kenneth Lee 2011-06-28